# LYUMJEV Tempo Pen

NDC: 0002-8235
Generic name: Insulin lispro-aabc
Labeler / Manufacturer: Eli Lilly and Company
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20200615
Marketing ended: 20271106
FDA application: BLA761109

## Active ingredients

- INSULIN LISPRO: 100 [iU]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0002-8235"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0002-8235
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c5a056e2-b568-4ca6-9ed8-79c010942d00